Completed PHASE3 INTERVENTIONAL 2-arm NCT01812525

Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations

Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3%

Sponsor: Raphaelle Jaquet-Pilloud

Conditions Moderate to Severe Bronchiolitis

Updated 5 times since 2017 Last updated: Aug 17, 2016 Started: Mar 31, 2013 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Moderate to Severe Bronchiolitis and is currently completed. Raphaelle Jaquet-Pilloud leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Raphaelle Jaquet-Pilloud
Swiss Foundation for the Health of Children and Adolescents

Data source: Hôpital de L'Enfance

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lausanne, Switzerland